Our data presented in this manuscript show that ERβ, a tamoxifen target, is highly expressed in DLBCL, and that exposure of DLBCL cell lines to tamoxifen (either alone or in combination with CHOP chemotherapy) results in apoptosis and growth inhibition in vitro and in vivo. Here, ESR2 is linked to diffuse large B-cell lymphoma.